GSK and Pfizer’s respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tuesday. The regulator conducted a postmarketing trial which suggested…[#item_full_content]
Germania, 1.700 miliardi in dieci anni. Svolta sul debito: Berlino si riarma
Marzo 7, 2025
Read More 2 minuti di lettura Supplementi Repubblica Gedi News Network La Stampa HuffPost Italia Fem Formula Passion Quotidiani locali La Provincia Pavese La Sentinella
